Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model

[1]  Stine H. Kresse,et al.  Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes , 2013, British Journal of Cancer.

[2]  P. Wei,et al.  Low expression of LOC285194 is associated with poor prognosis in colorectal cancer , 2013, Journal of Translational Medicine.

[3]  Fangting Wu,et al.  LncRNA loc285194 is a p53-regulated tumor suppressor , 2013, Nucleic acids research.

[4]  Eivind Hovig,et al.  Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma , 2012, PloS one.

[5]  Anne-Marie Cleton-Jansen,et al.  Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs , 2012, PloS one.

[6]  V. Thayanithy,et al.  Combinatorial Treatment of DNA and Chromatin-Modifying Drugs Cause Cell Death in Human and Canine Osteosarcoma Cell Lines , 2012, PloS one.

[7]  Anne-Marie Cleton-Jansen,et al.  Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data , 2012, Genes, chromosomes & cancer.

[8]  J. Squire,et al.  The Genetics of Osteosarcoma , 2012, Sarcoma.

[9]  O. Myklebost,et al.  Adipocyte differentiation of human bone marrow-derived stromal cells is modulated by microRNA-155, microRNA-221, and microRNA-222. , 2012, Stem cells and development.

[10]  A. Llombart‐Bosch,et al.  Functional characterization of osteosarcoma cell lines provides representative models to study the human disease , 2011, Laboratory Investigation.

[11]  M. Oursler,et al.  TGF-β Inducible Early Gene 1 Regulates Osteoclast Differentiation and Survival by Mediating the NFATc1, AKT, and MEK/ERK Signaling Pathways , 2011, PloS one.

[12]  Anne-Marie Cleton-Jansen,et al.  Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents , 2011, Clinical Cancer Research.

[13]  J. Downing,et al.  High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations. , 2010, Blood.

[14]  Anne-Marie Cleton-Jansen,et al.  Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours , 2010, BMC Research Notes.

[15]  M. Rosemann,et al.  Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma , 2010, Clinical Cancer Research.

[16]  J. Squire,et al.  Open Access Research Article Expression Analysis of Genes Associated with Human Osteosarcoma Tumors Shows Correlation of Runx2 Overexpression with Poor Response to Chemotherapy , 2022 .

[17]  Chi-Hung Lin,et al.  Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma. , 2009, International journal of oncology.

[18]  Zhaoming Lu,et al.  Potential role of Notch1 signaling pathway in laryngeal squamous cell carcinoma cell line Hep-2 involving proliferation inhibition, cell cycle arrest, cell apoptosis, and cell migration. , 2009, Oncology Report.

[19]  Stine H. Kresse,et al.  LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization , 2009, Genes, chromosomes & cancer.

[20]  G. Cagney,et al.  Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression , 2009, Molecular Psychiatry.

[21]  L. Donehower,et al.  Notch signaling contributes to the pathogenesis of human osteosarcomas. , 2009, Human molecular genetics.

[22]  O. Ludkovski,et al.  Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH , 2008, Cytogenetic and Genome Research.

[23]  M. Subramaniam,et al.  Role of TIEG1 in biological processes and disease states , 2007, Journal of cellular biochemistry.

[24]  S. Carty,et al.  HES1 Cooperates With pRb to Activate RUNX2‐Dependent Transcription , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  H. Gabra,et al.  The IgLON Family in Epithelial Ovarian Cancer: Expression Profiles and Clinicopathologic Correlates , 2005, Clinical Cancer Research.

[26]  J. Gu,et al.  Expression Profile of Cancer-Testis Genes in 121 Human Colorectal Cancer Tissue and Adjacent Normal Tissue , 2005, Clinical Cancer Research.

[27]  S. Knuutila,et al.  Gene amplifications in osteosarcoma—CGH microarray analysis , 2005, Genes, chromosomes & cancer.

[28]  Rainer Breitling,et al.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.

[29]  Shishir Shah,et al.  Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma , 2004, BMC Cancer.

[30]  D. Moss,et al.  Diglons are heterodimeric proteins composed of IgLON subunits, and Diglon-CO inhibits neurite outgrowth from cerebellar granule cells , 2004, Journal of Cell Science.

[31]  B. Teh,et al.  754: LSAMP and NORE1: Novel Genes in Hereditary and Sporadic Clear Cell Renal Cell Carcinomas (CCRCC) , 2004 .

[32]  C. Larsson,et al.  The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. , 2003, Cancer cell.

[33]  P. Meltzer,et al.  Mechanisms of sarcoma development , 2003, Nature Reviews Cancer.

[34]  G. Castellani,et al.  Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques. , 2003, European journal of cell biology.

[35]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[36]  P. Meltzer,et al.  Focus on sarcomas. , 2002, Cancer cell.

[37]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[38]  F. Tanaka,et al.  Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas , 2001, British Journal of Cancer.

[39]  Inge Jonassen,et al.  J-Express: exploring gene expression data using Java , 2001, Bioinform..

[40]  L. Michaux,et al.  LAGE‐1, a new gene with tumor specificity , 1998, International journal of cancer.

[41]  B. Riggs,et al.  Tissue, cell type, and breast cancer stage‐specific expression of a TGF‐β inducible early transcription factor gene , 1998, Journal of cellular biochemistry.

[42]  H. Tideman.  Abstract from international literatureBone cancers: H. D. Dorfman, B. Czerniak Cancer 1995: 75: 203–10 , 1995 .

[43]  P. Levitt,et al.  The limbic system-associated membrane protein is an Ig superfamily member that mediates selective neuronal growth and axon targeting , 1995, Neuron.

[44]  Y. Nakamura,et al.  Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. , 1992, Cancer research.

[45]  P. Levitt,et al.  A unique membrane protein is expressed on early developing limbic system axons and cortical targets , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  C. Fletcher,et al.  WHO classification of tumours of soft tissue and bone , 2013 .

[47]  J. Coindre.  [New WHO classification of tumours of soft tissue and bone]. , 2012, Annales de pathologie.

[48]  David Malkin,et al.  Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. , 2010, Cancer research.

[49]  J. Ingle,et al.  Functional role of KLF10 in multiple disease processes , 2010, BioFactors.

[50]  M. Kattan,et al.  Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. , 2004, The Journal of urology.

[51]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[52]  F. Mertens,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .

[53]  B. Czerniak,et al.  Bone cancers , 1995, Cancer.